Alpha Profiles · Company Profile

Annexon, Inc.

Canonical company identity and public leadership record.

https://registry.alpha.ac/companies/annexon-inc

Entity: Public listing published
Primary listing: NASDAQ: ANNX
Verification: Partially verified
Last reviewed: 2026-09-13T04:46:09.636156+00:00

Overview

Alpha's canonical identity and public leadership record for Annexon, Inc..

Canonical AEGIS identity graph

Executive leadership

Current, confirmed roles are shown only when both the person Profile and supporting source record satisfy the public projection boundary. A missing role is not evidence that it does not exist.

Executive team

11 public records

Douglas E. Love, Esq.

President, Chief Executive Officer and Class III Director

State: confirmed
Effective: Date not stated
Confidence: 94%
Evidence: ANNX executive roster sourceMay 3, 2026

Douglas Love

President, Chief Executive Officer and Class III Director

State: confirmed
Effective: From Apr 27, 2026
Confidence: 94%
Evidence: ANNX DEF 14A executive officersApr 27, 2026

Jamie Dananberg

EVP Chief Medical Officer

State: confirmed
Effective: From Apr 27, 2026
Confidence: 94%
Evidence: ANNX DEF 14A executive officersApr 27, 2026

Jamie Dananberg, M.D.

EVP Chief Medical Officer

State: confirmed
Effective: Date not stated
Confidence: 94%
Evidence: ANNX executive roster sourceMay 3, 2026

Jennifer Lew

EVP Chief Financial Officer

State: confirmed
Effective: From Apr 27, 2026
Confidence: 94%
Evidence: ANNX DEF 14A executive officersApr 27, 2026

Michael Overdorf

EVP Chief Business Officer

State: confirmed
Effective: From Apr 27, 2026
Confidence: 94%
Evidence: ANNX DEF 14A executive officersApr 27, 2026

Michael Overdorf, M.B.A.

EVP Chief Business Officer

State: confirmed
Effective: Date not stated
Confidence: 94%
Evidence: ANNX executive roster sourceMay 3, 2026

Rick Artis

EVP Chief Scientific Officer

State: confirmed
Effective: From Apr 27, 2026
Confidence: 94%
Evidence: ANNX DEF 14A executive officersApr 27, 2026

Rick Artis, Ph.D.

EVP Chief Scientific Officer

State: confirmed
Effective: Date not stated
Confidence: 94%
Evidence: ANNX executive roster sourceMay 3, 2026

Ted Yednock

EVP Chief Innovation Officer

State: confirmed
Effective: From Apr 27, 2026
Confidence: 94%
Evidence: ANNX DEF 14A executive officersApr 27, 2026

Ted Yednock, Ph.D.

EVP Chief Innovation Officer

State: confirmed
Effective: Date not stated
Confidence: 94%
Evidence: ANNX executive roster sourceMay 3, 2026

Governance leadership

Boards & Committees

Board and committee assignments appear only when the canonical public projection retains a current role and supporting source. Unpublished records are not interpreted as absence.

Record as of Sep 13, 2026. Chair, executive office, Lead Independent Director and committee appointments retain their separate source roles. A complete board composition denominator and committee charters are not established by a partial roster.